Joshua Reuss, MD, and Patrick Forde, MD, PhD, talked with moderator Isabel Preeshagul, DO, MBS, about developments from the 2026 IASLC Targeted Therapies of Lung Cancer meeting.
Watch the replay below.
Special thanks to our sponsors:
AbbVie
Boehringer Ingelheim
Eisai